Chemistry:Terguride

Terguride
Clinical data
Trade names	Teluron
Other names	Dironyl; Mysalfon; trans-Dihydrolisuride; Transdihydrolisuride; TDHL; SH-406; VUFB-6638; ZK-31224; N,N-Diethyl-N'-[(8α)-6-methylergolin-8-yl]urea
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral
ATC code	G02CB06 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name 3-[(6aR,9S,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]-1,1-diethylurea;
CAS Number	37686-84-3;
PubChem CID	443951;
IUPHAR/BPS	56;
DrugBank	DB13399 ;
ChemSpider	392004;
UNII	21OJT43Q88;
KEGG	D01348 ;
Chemical and physical data
Formula	C20H28N4O
Molar mass	340.471 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCN(CC)C(=O)N[C@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)C;
	InChI InChI=1S/C20H28N4O/c1-4-24(5-2)20(25)22-14-10-16-15-7-6-8-17-19(15)13(11-21-17)9-18(16)23(3)12-14/h6-8,11,14,16,18,21H,4-5,9-10,12H2,1-3H3,(H,22,25)/t14-,16+,18+/m0/s1; Key:JOAHPSVPXZTVEP-YXJHDRRASA-N;
	(verify)

Short description: Chemical compound

Pharmacology

Pharmacodynamics

Terguride acts as an agonist of the dopamine D₂ receptor and as an antagonist of the serotonin 5-HT_2A and 5-HT_2B receptors, among other actions.^{[citation needed]}

As an antagonist of the 5-HT_2B receptor, terguride is not associated with cardiac valvulopathy.^[1]

Activities of terguride at various sites^[2]^[3]^[4]^[5]
Site	Affinity (K_i [nM])	Efficacy (E_max [%])	Action
D₁	28	?	?
D_2S	0.81	39	Partial agonist
D_2L	1.1	0	Silent antagonist
D₃	1.0	36	Partial agonist
D₄	8.1	0	Silent antagonist
D₅	23	?	?
5-HT_1A	3.5	71	Partial agonist
5-HT_1B	257	37	Partial agonist
5-HT_1D	16	62	Partial agonist
5-HT_2A	4.8	49	Partial agonist
5-HT_2B	7.1	0	Silent antagonist
5-HT_2C	48	0	Silent antagonist
5-HT₇	8–42	?	?
α_1A	3.5	0	Silent antagonist
α_1B	35	?	?
α_1D	3.9	?	?
α_2A	0.30	0	Silent antagonist
α_2B	0.45	0	Silent antagonist
α_2C	0.76	0	Silent antagonist
α_2D	1.5	?	?
β₁	661	?	?
β₂	20	?	?
H₁	339	?	?
M₁	>10,000	?	?
Notes: All receptors are human except α_2D-adrenergic, which is rat (no human counterpart), and 5-HT₇, which was guinea pig.^[2]^[5]

Research

Serotonin stimulates the proliferation of pulmonary artery smooth muscle cells, and induces fibrosis in the wall of pulmonary arteries. Together, this causes vascular remodeling and narrowing of the pulmonary arteries. These changes result in increased vascular resistance and PAH. Due to the potential anti-proliferative and anti-fibrotic activity of terguride, this potential medicine could offer the hope of achieving reversal of pulmonary artery vascular remodeling and attenuation of disease progression.^[6] In May 2008, terguride was granted orphan drug status for the treatment of pulmonary arterial hypertension.^[7] In May 2010 Pfizer purchased worldwide rights for the drug.^[8] However, development was discontinued in 2011.

References

↑ "Ergotamine and nicergoline - facts and myths". Pharmacol Rep 67 (2): 360–3. April 2015. doi:10.1016/j.pharep.2014.10.010. PMID 25712664.
↑ ^2.0 ^2.1 "Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes". J Pharmacol Exp Ther 303 (2): 791–804. November 2002. doi:10.1124/jpet.102.039867. PMID 12388666.
↑ "Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor". J Pharmacol Exp Ther 303 (2): 805–14. November 2002. doi:10.1124/jpet.102.039875. PMID 12388667.
↑ "Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes". J Pharmacol Exp Ther 303 (2): 815–22. November 2002. doi:10.1124/jpet.102.039883. PMID 12388668.
↑ ^5.0 ^5.1 "PDSP Database - UNC". https://pdsp.unc.edu/databases/pdsp.php?testFreeRadio=testFreeRadio&testLigand=Terguride&doQuery=Submit+Query.
↑ "5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure". BioMed Research International 2015: 438403. 2015. doi:10.1155/2015/438403. PMID 25667920.
↑ Presseportal (Swiss press portal, in German)
↑ "TheDay.com 5/10/2010". http://www.theday.com/article/20100513/BIZ02/305139376/1044.

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Terguride. Read more

[pmid25712664-1] "Ergotamine and nicergoline - facts and myths". Pharmacol Rep 67 (2): 360–3. April 2015. doi:10.1016/j.pharep.2014.10.010. PMID 25712664.

[pmid12388666-2] 2.0 ^2.1 "Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes". J Pharmacol Exp Ther 303 (2): 791–804. November 2002. doi:10.1124/jpet.102.039867. PMID 12388666.

[pmid12388667-3] "Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor". J Pharmacol Exp Ther 303 (2): 805–14. November 2002. doi:10.1124/jpet.102.039875. PMID 12388667.

[pmid12388668-4] "Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes". J Pharmacol Exp Ther 303 (2): 815–22. November 2002. doi:10.1124/jpet.102.039883. PMID 12388668.

[PDSPKiDatabase-5] 5.0 ^5.1 "PDSP Database - UNC". https://pdsp.unc.edu/databases/pdsp.php?testFreeRadio=testFreeRadio&testLigand=Terguride&doQuery=Submit+Query.

[6] "5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure". BioMed Research International 2015: 438403. 2015. doi:10.1155/2015/438403. PMID 25667920.

[7] Presseportal (Swiss press portal, in German)

[8] "TheDay.com 5/10/2010". http://www.theday.com/article/20100513/BIZ02/305139376/1044.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

v t e Prolactin inhibitors and anti-inflammatory products for vaginal administration (G02CB–G02CC)
Prolactin inhibitors	Bromocriptine Cabergoline Lisuride Metergoline Quinagolide Terguride
Anti-inflammatory products for vaginal administration	Benzydamine Ibuprofen Flunoxaprofen Naproxen

v t e Ergolines
Lysergic acid derivatives	2-Bromo-LSD (BOL-148) Bromocriptine Cabergoline Dihydroergocornine Dihydroergocristine Dihydroergocryptine Dihydroergometrine (Dihydroergonovine, Dihydroergobasine) Dihydroergosine Dihydroergotamine Epicriptine Ergine (LSA; LA-111; Lysergamide) Ergocornine Ergocristine Ergocryptine Ergoloid (Dihydroergotoxine) Ergometrine (Ergonovine, Ergobasine) Ergometrinine Ergotamine Ergotoxine Ergovaline Lisuride LSD LSH Lysergic Acid Lysergic acid cyclobutylamide Lysergic acid cyclopentylamide Lysergic Acid Methyl Ester Lysergol Mesulergine Metergoline Methergine (Methylergometrine, Methylergonovine, Methylergobasine) Methysergide Pergolide Syntometrine
Psychedelic lysergamides	1B-LSD 1P-ETH-LAD 1P-LSD AL-LAD ALD-52 BU-LAD CYP-LAD DAL DAM-57 ECPLA Ergonovine ETFELA ETH-LAD IP-LAD LAMPA LAE-32 LSD LPD-824 LSM-775 LSH LSD-Pip Lysergic Acid 2-Butylamide Lysergic Acid 2,4-Dimethylazetidide Lysergic Acid 3-Pentylamide Methylergonovine MIPLA MLD-41 PARGY-LAD PRO-LAD
clavines	agroclavine elymoclavine lysergol festuclavine fumigaclavine A fumigaclavine B fumigaclavine C
Other ergolines	Ergoline
Natural sources	Achnatherum robustum (Sleepy Grass) Claviceps spp. (Ergot) Morning glory: Argyreia nervosa (Hawaiian Baby Woodrose), Ipomoea spp.(Morning Glory, Tlitliltzin, Badoh Negro), Rivea corymbosa (Coaxihuitl, Ololiúqui)

Anonymous

Search

Chemistry:Terguride

Namespaces

More

Page actions

Contents

Pharmacology

Pharmacodynamics

Research

References

Navigation

Navigation

Help

Translate

Wiki tools

Wiki tools

Anonymous

Search

Chemistry:Terguride

Pharmacology

Pharmacodynamics

Research

References

Navigation

Wiki tools

Page tools

Other projects

Categories